Optogenetic FGFR1 Stimulation for Protein-Free Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell culture systems rely heavily on expensive and thermo-unstable recombinant proteins for maintaining pluripotency, which are costly and impractical for large-scale manufacturing and clinical applications.
Innovation Solution
Development of a novel culture system using a fusion protein comprising the intracellular domain of the fibroblast growth factor 1 receptor (FGFR1) fused to a light-oxygen-voltage sensing (LOV) domain, enabling optical induction of the FGF signaling pathway without exogenous FGF2 protein supplementation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If recombinant FGF2 protein is used to maintain pluripotency of stem cells, then pluripotency is maintained, but cost increases and thermal stability decreases
Solution Approach 1:
The patent replaces the biochemical system (recombinant FGF2 protein) with an optogenetic system. Specifically, it uses a fusion protein comprising a photosensitive domain (LOV or Cry2) and an FGFR1 intracellular domain, activated by blue light illumination to induce dimerization and activate FGF signaling pathway, thereby maintaining pluripotency without exogenous FGF2 protein
Solution Approach 2:
The patent changes the activation mechanism from chemical (protein-ligand interaction) to physical (light-induced conformational change). The photosensitive domain undergoes light-induced dimerization or conformational change upon blue light illumination, which triggers the FGF signaling pathway activation, replacing the thermal and chemical instability of recombinant proteins with optically controllable stability
2Reliability
If recombinant FGF2 protein is used to maintain pluripotency, then pluripotency is maintained, but manufacturing cost increases
Solution Approach 1:
The patent replaces the expensive recombinant FGF2 protein system with a cost-effective optogenetic system. The fusion protein (photosensitive domain + FGFR1 intracellular domain) is expressed in the stem cells themselves, and activation is achieved through inexpensive blue light illumination, eliminating the need for continuous addition of costly recombinant proteins
Solution Approach 2:
The stem cells are genetically modified to express the opto-FGFR1 fusion protein, making them self-sufficient for FGF signaling activation. The cells themselves produce the photosensitive receptor, and light illumination provides the activation signal, eliminating dependence on external protein supplementation
3Reliability
If recombinant FGF2 protein is used for stem cell culture, then pluripotency is maintained, but system complexity increases
Solution Approach 1:
The patent extracts and eliminates the need for complex external protein supplementation systems. By genetically encoding the photosensitive FGF receptor in the stem cells themselves, the system removes the requirement for external FGF2 protein addition, media changes, and associated handling complexity
Solution Approach 2:
The opto-FGFR1 fusion protein serves multiple functions: it acts as both the FGF receptor and the light-sensing element. The photosensitive domain (LOV or Cry2) provides both structural function and optical activation capability, simplifying the system by combining multiple functions into a single molecular entity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Maintains pluripotency of stem cells with high precision and cost-effectiveness, allowing differentiation into three germ layers without daily protein supplementation, suitable for clinical trials and animal cellular agriculture.
Implementation Method 1
by absorbing energy from the photons in excitation light, they can undergo conformational changes, rearrange inter- or intra-protein contacts, and modulate inter-or intra-protein interactions
Implementation Method 2
a photosensitive protein Cry2 homo-oligomerizes, and LOV domain homo-dimerizes, both within seconds when illuminated with stimulatory light (∼470 nm)
Data Source
AI summary
The present invention relates to the field of stem cells. More specifically, the present invention provides compositions and methods for using optogenetics to sustain the pluripotency of stem cells. In one embodiment, a vector comprises a nucleotide sequencing encoding a fusion protein comprising the intracellular domain of fibroblast growth factor 1 receptor (FGFR1) and a photoactivatable domain.